Metabolite/Component | Mol.wt.a | AUC0–72 hb | Percentage of Total Radioactivity AUC0–72 h |
---|---|---|---|
g/mol | nmol·h/l | ||
M14 | 351.4 | 4536 ± 1948 | 9.21 ± 5.85 |
M13 | 301.3 | 231 ± 38 | 0.439 ± 0.175 |
M15 | 285.3 | 4688 ± 2283 | 9.15 ± 5.36 |
M16 | 271.4 | 628 ± 444 | 1.21 ± 1.02 |
M18 | 347.4 | 4766 ± 939 | 8.77 ± 2.4 |
M19 + M20c | 418.5/505.5 | 2557 ± 1759 | 4.18 ± 1.54 |
M22 | 505.5 | 2147 ± 449 | 3.89 ± 0.65 |
M23 + M24c | 345.4/400.4 | 1689 ± 713 | 3.14 ± 1.72 |
M25 + M26c | 255.4/409.5 | 1964 ± 1392 | 3.51 ± 2.75 |
M27 | 359.4 | 1829 ± 1716 | 2.86 ± 1.7 |
M28 | 375.4 | 547 ± 191 | 0.956 ± 0.14 |
M7 | 329.4 | 462 ± 435 | 0.734 ± 0.556 |
M6 | 343.4 | 6996 ± 1638 | 12.5 ± 1.63 |
M29 | 505.5 | 639 ± 64.7 | 1.18 ± 0.22 |
M5 | 489.5 | 1917 ± 568 | 3.42 ± 0.75 |
M3 | 329.4 | 1483 ± 1030 | 2.43 ± 0.88 |
M2 | 329.4 | 1002 ± 926 | 1.56 ± 0.93 |
M1 | 329.4 | 1706 ± 1659 | 2.63 ± 1.7 |
M30 | 345.4 | 3501 ± 2912 | 5.54 ± 2.8 |
M31 | 357.4 | 1153 ± 276 | 1.99 ± 0.8 |
Mavoglurant | 313.4 | 7197 ± 6667 | 11.2 ± 7.67 |
Mavoglurant (by LC-MS/MS)d | 313.4 | 7098 ± 6917 | NA |
M12 | 327.4 | 549 ± 388 | 0.821 ± 0.355 |
Sum of additional components | — | 578 ± 635 | 0.896 ± 0.724 |
Total components detected | — | 52,339 ± 18,508 | 91.5 ± 4.55 |
Lost during sample processing | — | 4490 ± 2358 | 8.45 ± 4.53 |
Total components in the original sample | — | 56,829 ± 17,844 | 100 |
NA, not applicable.
↵a The molecular weights (Mol.wt.) of the components are calculated from the elemental composition listed in Table 2.
↵b To obtain ng·h/ml units, multiply the AUC value with the metabolite’s mol.wt. divided by 1000; for total radioactivity, the reference mol.wt. of mavoglurant (313.4) divided by 1000 is used to obtain ng-eq·h/ml units.
↵c Coeluting metabolites. The relative percentages in the peak could not be quantified by LC-MS with off-line radioactivity detection.
↵d Mavoglurant AUC0–72 h calculated from values measured by LC-MS/MS.